Skip to Main Content

Author Details

Sebastian Brabetz
Hopp Children's Cancer Center Heidelberg (KiTZ)
2016
19
16
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37679810Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.Genome Med2023
37679810Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.Genome Med2023
35475274Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma.Neurooncol Adv2022
35475274Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma.Neurooncol Adv2022
34719887Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion.Adv Sci (Weinh)2021
34719887Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion.Adv Sci (Weinh)2021
33046443Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma.Cancer Res2020
33046443Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma.Cancer Res2020
31477715YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.Nat Commun2019
31802000The molecular landscape of ETMR at diagnosis and relapse.Nature2019
31477715YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.Nat Commun2019
31802000The molecular landscape of ETMR at diagnosis and relapse.Nature2019
29489754The landscape of genomic alterations across childhood cancers.Nature2018
30349086A biobank of patient-derived pediatric brain tumor models.Nat Med2018
30205043Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.Cancer Cell2018
30332335Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial.J Clin Oncol2018
29489754The landscape of genomic alterations across childhood cancers.Nature2018
29753700Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.Lancet Oncol2018
30205043Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.Cancer Cell2018
30349086A biobank of patient-derived pediatric brain tumor models.Nat Med2018
30332335Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial.J Clin Oncol2018
29753700Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.Lancet Oncol2018
28002790Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.Oncotarget2017
28482026Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.Neuro Oncol2017
29092942PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models.Cancer Res2017
28002790Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.Oncotarget2017
28482026Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.Neuro Oncol2017
29092942PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models.Cancer Res2017
26919435New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.Cell2016
26923874Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.Cancer Cell2016
26977882HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.Cancer Cell2016
26856307Telomere dysfunction and chromothripsis.Int J Cancer2016
26455320Tumour-suppression function of KLF12 through regulation of anoikis.Oncogene2016
26455320Tumour-suppression function of KLF12 through regulation of anoikis.Oncogene2016
26856307Telomere dysfunction and chromothripsis.Int J Cancer2016
26919435New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.Cell2016
26923874Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.Cancer Cell2016
26977882HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.Cancer Cell2016
  • 1 - 38 of 38

Recommended Authors

Kyle S Smith
St. Jude Children's Research Hospital
Career Start Year 2018
Number of shared co-authors 69
Chelsea Mayoh
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 34
Jason K Sa
Korea University, College of Medicine
Career Start Year 2015
Number of shared co-authors 5
Patryk Skowron
University of Toronto
Career Start Year 2015
Number of shared co-authors 46
Komal S Rathi
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 17
Carl Koschmann
University of Michigan-Ann Arbor
Career Start Year 2010
Number of shared co-authors 27
Xin Wang
The Chinese University of Hong Kong, Prince of Wales Hospital
Career Start Year 2010
Number of shared co-authors 55
Stephen C Mack
St Jude Children's Research Hospital
Career Start Year 2009
Number of shared co-authors 72
Payal Jain
Maharaja Agrasen Medical College
Career Start Year 2009
Number of shared co-authors 14
Florence M G Cavalli
Institut Curie, PSL Research University
Career Start Year 2009
Number of shared co-authors 86
David J H Shih
University of Texas MD Anderson Cancer Center Houston
Career Start Year 2009
Number of shared co-authors 67
Adrian M Dubuc
Dana-Farber Cancer Institute
Career Start Year 2008
Number of shared co-authors 54
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Career Start Year 2008
Number of shared co-authors 69
Chitra Venugopal
McMaster Stem Cell and Cancer Research Institute
Career Start Year 2006
Number of shared co-authors 10
Mario L Suv??
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 25
Livia Garzia
The Research Institute of the McGill University Health Centre, McGill University
Career Start Year 2003
Number of shared co-authors 61
Amy Smith
Arnold Palmer Hospital for Children
Career Start Year 2003
Number of shared co-authors 61
Massimo Squatrito
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 6
Sheila K Singh
McMaster University
Career Start Year 2001
Number of shared co-authors 26
Tamra E Werbowetski-Ogilvie
University of Manitoba
Career Start Year 2001
Number of shared co-authors 26
Brian R Rood
Brain Tumor Institute, Children's National Hospital
Career Start Year 1998
Number of shared co-authors 36
Rajeev Vibhakar
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Career Start Year 1997
Number of shared co-authors 55
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 10
Steven C Clifford
Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer
Career Start Year 1994
Number of shared co-authors 75
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 17
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year 1992
Number of shared co-authors 56
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 25
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 16
William A Weiss
University of California san francisco
Career Start Year 1985
Number of shared co-authors 64
Cynthia Hawkins
The Hospital for Sick Children
Career Start Year 1980
Number of shared co-authors 80

Collaborators

Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 18
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 17
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 11
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 11
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 8
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 7
Lukas Chavez
University of California San Diego
Co-authored papers 7
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 6
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 6
Susanne Gr??bner
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 6
James M Olson
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 5
Jan Koster
Amsterdam University Medical Centers location AMC
Co-authored papers 5
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers 5
Ivo Buchhalter
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Co-authored papers 5
David Capper
Charite University Medicine Berlin
Co-authored papers 5
Andreas von Deimling
Co-authored papers 5
Kristian W Pajtler
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Co-authored papers 5
Amar Gajjar
St. Jude Children's Research Hospital
Co-authored papers 4
Roland Eils
Berlin Institute of Health (BIH) and Charite
Co-authored papers 4
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 4
Dominik Sturm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 4
Jan O Korbel
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 4
Katja von Hoff
Co-authored papers 4
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 4
Xiao-Nan Li
Northwestern University
Co-authored papers 4
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 4
Laura Sieber
Preclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 4
Huriye Seker-Cin
Institute of Pathology, Heidelberg University Hospital
Co-authored papers 3
Ulrich Sch??ller
University Medical Center Hamburg-Eppendorf
Co-authored papers 3
Martin Sill
Co-authored papers 3
Release 1.2